Evidence-based Advantage RxResults specializes in evidence-based pharmacy risk management, presenting a compelling value proposition for health plans seeking to identify savings and mitigate medication risk through validated, data-driven strategies.

Strategic Partnerships Longstanding collaborations with universities and healthcare technology firms (notably University of Arkansas for Medical Sciences College of Pharmacy and Tabula Rasa HealthCare) signal a strong path to co-developed solutions and credibility with health plan clients.

Mid-market Focus With 11-50 employees and annual revenue in the 25 to 50 million range, RxResults sits in a mid-market niche that can be targeted by regional and national health plans looking for specialized risk management capabilities without enterprise-scale pricing.

Technology Stack Fit Reliance on common enterprise tools (SQL Server, SSIS, Google Tag Manager, Nginx) indicates compatibility with existing plan operations and analytics environments, easing integration for prospective clients.

Funding & Growth Potential Current funding of around 4.3 million and reported revenue growth potential position RxResults as an attractive partner for carriers and PBMs seeking scalable evidence-based pharmacy risk management without committing to larger incumbents.